A new survey highlights the importance of customer reference data to digital transformation and analyses ways pharma companies can improve the quality of their datasets.
The FDA has approved Akebia Therapeutics’ vadadustat as a treatment for anaemia caused by chronic kidney disease (CKD) in dialysis patients, becoming the first rival to GS